|
ZNF234 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.332100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.980200E-02 |
| Normal-vs-Stage2 |
2.271800E-01 |
| Normal-vs-Stage3 |
3.567600E-04 |
| Normal-vs-Stage4 |
1.88799999999434E-05 |
| Stage1-vs-Stage2 |
7.596600E-01 |
| Stage1-vs-Stage3 |
1.559980E-02 |
| Stage1-vs-Stage4 |
9.664600E-03 |
| Stage2-vs-Stage3 |
1.290030E-01 |
| Stage2-vs-Stage4 |
4.550300E-02 |
| Stage3-vs-Stage4 |
2.721600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.433600E-02 |
| Normal-vs-AfricanAmerican |
1.596390E-01 |
| Normal-vs-Asian |
1.071180E-01 |
| Caucasian-vs-AfricanAmerican |
8.363600E-01 |
| Caucasian-vs-Asian |
6.377000E-01 |
| AfricanAmerican-vs-Asian |
5.650400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.976800E-03 |
| Normal-vs-Female |
9.379800E-01 |
| Male-vs-Female |
2.477600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.467840E-01 |
| Normal-vs-Extreme_Weight |
1.502670E-03 |
| Normal-vs-Obese |
1.696190E-01 |
| Normal-vs-Extreme_Obese |
6.191500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.608200E-01 |
| Normal_Weight-vs-Obese |
7.990000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.398800E-01 |
| Extreme_Weight-vs-Obese |
1.137410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.857600E-01 |
| Obese-vs-Extreme_Obese |
5.104600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.426800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.714200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.522440E-02 |
| Normal-vs-Age(81-100Yrs) |
1.388390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.937800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.954400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.832300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.900200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.364300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.741640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.101800E-01 |
| Normal-VS-Type2 PRCC |
1.97950000002667E-06 |
| Normal-VS-KIRP CIMP |
8.780300E-02 |
| Normal-VS-Unclassified PRCC |
4.311400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.60431999999266E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.328990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.939800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.695200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.068400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.129600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.024100E-03 |
| Normal-vs-N1 |
3.769800E-02 |
| Normal-vs-N2 |
1.600240E-03 |
| N0-vs-N1 |
9.450000E-01 |
| N0-vs-N2 |
1.986600E-01 |
| N1-vs-N2 |
3.144000E-01 |
|
|
